Other languages China Meheco Group Co., Ltd.

Equities

600056

CNE000000Q29

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
11.34 ^CNY	+0.09%		+0.18%	+1.52%

29/04	China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04	China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection	20/02
Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation	20/02
Meheco's Unit Gets Nod to Market Peramivir Injection; Shares Down 4%	05/02
Meheco Unit's Antibiotic Passes Regulatory Evaluation in China	24/01
China Meheco’s Hypertension Drug Passes Generic Consistency Evaluation	16/11
China Meheco Group's Drugs Chosen for China's Centralized Drug Procurement	08/11
China Meheco Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27
China Meheco Group Unit's Norfloxacin Capsules Passes Drug Regulator's Evaluation	13/23/13
China Meheco’s Antibiotic Passes Generic Consistency Evaluation	04/23/04
China Meheco Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24
China Medicine Health Industry Gets Registration Certificate for Sitafloxacin Tablets	16/23/16
New rules to dampen Chinese interest to list in Europe, say bankers	22/23/22
China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28
China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28
China Medicine Health Industry Unit Gets Regulatory Nod for Gastrointestinal Bleeding Drug	08/23/08
China Medicine Health Industry Unit's Injection Passes Regulator's Consistency Evaluation	06/23/06
China Meheco’s Generic Azithromycin Passes Consistency Test	27/23/27
China Meheco Rents Office Property for 57 Million Yuan	13/23/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China Meheco Group Co., Ltd.

Equities

600056

CNE000000Q29

Other languages

Filters